Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

Study Claims COVID Vaccines Linked to Surge in Deaths, Raising Serious Concerns** A comprehensive study examining nearly 100 million individuals has sparked alarm by asserting a ...

Warning! Sweeping changes in public health are on the rise. The latest word, according to Stat, is that the Department of ...

In recent years, the demand for versatile outdoor spaces has skyrocketed, leading homeowners to explore innovative solutions ...

Hardel Sherrell was in Beltrami County Jail awaiting trial when he died on September 2, 2018 from a lack of medical care for ...

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

End-of-life conversations. Grieving for a lost sense of taste. A devastating side effect. And a new vision of the world.

The global Therapeutic Plasma Exchange Market, valued at US$ 1.5 billion in 2022, is projected to grow at a compound annual ...

It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...

Replying to a debate in the House on the GBS outbreak, the health minister said it was not a contagious disease like Covid-19 ...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

Pune: The Pune Municipal Corporation (PMC) on Tuesday made a budgetary allocation of Rs 569.89 crore for the health ...